ARTICLE | Company News
Angiogenesis Technologies Inc. deal
May 8, 1995 7:00 AM UTC
Angiogenesis received an exclusive worldwide license from Mount Sinai Hospital Corp. (Toronto) to technology that uses vanadate (salts and esters of vanadic acid) and related compounds to treat prolif...